Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001913156 | SCV002169315 | uncertain significance | Imerslund-Grasbeck syndrome | 2022-07-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1401828). This variant has not been reported in the literature in individuals affected with CUBN-related conditions. This variant is present in population databases (rs560009723, gnomAD 0.05%). This sequence change affects codon 1994 of the CUBN mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the CUBN protein. |
Fulgent Genetics, |
RCV002482790 | SCV002778859 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2021-11-12 | criteria provided, single submitter | clinical testing |